Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Krummel et al., 1988 - Google Patents

Transforming growth factor beta (TGF-β) induces fibrosis in a fetal wound model

Krummel et al., 1988

Document ID
2475412010840953513
Author
Krummel T
Michna B
Thomas B
Sporn M
Nelson J
Salzberg A
Cohen I
Diegelmann R
Publication year
Publication venue
Journal of pediatric surgery

External Links

Snippet

The adult cellular response to tissue injury is characterized by acute inflammation followed eventually by fibroblast proliferation and collagen synthesis. Fetal tissue responses to injury differ markedly from those of the adult; an early acute inflammatory response is absent, few …
Continue reading at www.sciencedirect.com (other versions)
  • 230000001605 fetal 0 title abstract description 48

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence

Similar Documents

Publication Publication Date Title
Krummel et al. Transforming growth factor beta (TGF-β) induces fibrosis in a fetal wound model
Clark et al. Fibronectin is produced by blood vessels in response to injury.
Colwell et al. Fetal wound healing
Desmoulière et al. The role of the myofibroblast in wound healing and fibrocontractive diseases
Duncan et al. Connective tissue growth factor mediates transforming growth factor β‐induced collagen synthesis: down‐regulation by cAMP
Harrison et al. The mechanism of skin graft contraction: an update on current research and potential future therapies
Clark et al. Fibronectin beneath reepithelializing epidermis in vivo: sources and significance.
CA2105652C (en) Reducing wound scarring with antibodies to growth factors
JP4065846B2 (en) Creation of tissue engineered female reproductive organs
JP3040815B2 (en) Proliferative effect of leukemia inhibitory factor on associated cells
Geer et al. Fibrin promotes migration in a three-dimensional in vitro model of wound regeneration
Depalma et al. Characterization and quantitation of wound matrix in the fetal rabbit
Olutoye et al. Lower cytokine release by fetal porcine platelets: a possible explanation for reduced inflammation after fetal wounding
Siebert et al. Fetal wound healing: a biochemical study of scarless healing
EP3479831B1 (en) Composition comprising thrombin-treated stem cell-derived exosome for use in treating skin wound
US5720981A (en) Epidermal cell extracts and method to enhance wound healing and regenerate epidermis
US20070154529A1 (en) Uses of dna binding proteins
Lemaire et al. Alveolar macrophage stimulation of lung fibroblast growth in asbestos-induced pulmonary fibrosis.
US6503504B1 (en) Delivery of bioactive compounds to an organism
JP2001506268A (en) Use of peptides to improve uptake of skin grafts
JP2000508922A (en) Skin regeneration using mesenchymal stem cells
WO1991010424A1 (en) Method of inhibiting angiogenesis of tumors
Sawai et al. Hyaluronic acid of wound fluid in adult and fetal rabbits
Kurita et al. Immunohistochemical localization of basic fibroblast growth factor in wound healing sites of mouse skin
EP0437281B1 (en) Composition comprising acidic fibroblast growth factor (aFGF)